Prasugrel Tablet, Film Coated
Product Images NDC 43817-239

9 FDA label images from Panacea Biotec Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Prasugrel (NDC 43817-239). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Panacea Biotec Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (167121ca 708a 404c 83c1 C93d6e81bf28 01)

Image (167121ca 708a 404c 83c1 C93d6e81bf28 01)
A line graph comparing Non-CABG-related TIMI major or minor bleeding events (%) over days from randomization for Prasugrel 5 mg tablets and Clopidogrel. The vertical axis shows bleeding event percentage, and the horizontal axis shows days up to 450. Prasugrel tablets show higher bleeding event rates compared to Clopidogrel across the timeline.*
FDA Label Image

Image (167121ca 708a 404c 83c1 C93d6e81bf28 02)

Image (167121ca 708a 404c 83c1 C93d6e81bf28 02)
Chemical structure diagram of the active ingredient in PRASUGREL 5 mg, showing the molecular arrangement including a fluorophenyl group, thienopyridine ring, and other functional groups, along with a hydrochloride moiety.*
FDA Label Image

Image (167121ca 708a 404c 83c1 C93d6e81bf28 03)

Image (167121ca 708a 404c 83c1 C93d6e81bf28 03)
A line graph depicting inhibition of platelet aggregation (%) over time (hours). The x-axis shows time up to 24 hours, while the y-axis ranges from -20% to 100% inhibition. Data points represent mean values with standard deviation bars at various time intervals, showing inhibition stabilizing around 75-80% after 2 hours using 20 µM ADP.*
FDA Label Image

Image (167121ca 708a 404c 83c1 C93d6e81bf28 04)

Image (167121ca 708a 404c 83c1 C93d6e81bf28 04)
A line graph comparing the percentage of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke over days from randomization for Prasugrel tablets versus Clopidogrel in patients with UA/NSTEMI. The graph shows lower event rates for Prasugrel with statistical significance noted (p=0.002). An inset graph highlights data for the first 7 days with a p-value of 0.017.*
FDA Label Image

Image (167121ca 708a 404c 83c1 C93d6e81bf28 05)

Image (167121ca 708a 404c 83c1 C93d6e81bf28 05)
A line graph comparing cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke percentages over days from randomization between Prasugrel Tablets and Clopidogrel in STEMI patients. The graph shows two curves with Clopidogrel consistently higher than Prasugrel Tablets over approximately 450 days. An inset graph displays a similar comparison over 7 days.*
FDA Label Image

Image (167121ca 708a 404c 83c1 C93d6e81bf28 06)

Image (167121ca 708a 404c 83c1 C93d6e81bf28 06)
A forest plot titled 'Baseline Characteristics' comparing the percent events between Prasugrel Tablets and Clopidogrel across various patient subgroups such as age, gender, body weight, region, diabetes status, metabolic syndrome, previous medical conditions, time from symptom onset, stent type, and GP IIb/IIIa inhibitor use. The plot depicts hazard ratios with confidence intervals, indicating which treatment is favored for each subgroup.*
FDA Label Image

Image (167121ca 708a 404c 83c1 C93d6e81bf28 07)

Image (167121ca 708a 404c 83c1 C93d6e81bf28 07)
A forest plot comparing percent events between Prasugrel tablets and Clopidogrel across various baseline characteristics such as age, gender, body weight, region, diabetes status, metabolic syndrome, previous medical conditions, and treatment details. The plot shows hazard ratios with confidence intervals, illustrating relative effectiveness for subgroups in a clinical study.*
FDA Label Image

Prasugrel Tablets Usp 5 mg (167121ca 708a 404c 83c1 C93d6e81bf28 08)

Prasugrel Tablets Usp 5 mg (167121ca 708a 404c 83c1 C93d6e81bf28 08)
Label for Prasugrel Tablets 5 mg by Panacea Biotec Limited. The label indicates a package of 30 tablets with NDC 43817-239-01. It includes usage instructions such as keeping the tablets in the original container and not removing the desiccant. The label also displays a round, orange tablet imprinted with '5'.*
FDA Label Image

Prasugrel Tablets Usp 10 mg (167121ca 708a 404c 83c1 C93d6e81bf28 09)

Prasugrel Tablets Usp 10 mg (167121ca 708a 404c 83c1 C93d6e81bf28 09)
Label for Prasugrel Tablets 10 mg, containing 30 tablets per bottle. The label indicates prescription use only and includes storage instructions. The manufacturer is Panacea Biotec Limited. The label also depicts an image of a single round, brown tablet marked with "10".*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.